期刊文献+

美国食品和药物管理局质量量度管理的简介及启示 被引量:7

Brief introduction on United States Food and Drug Administration's quality metrics and its implication
原文传递
导出
摘要 美国食品和药物管理局《质量量度要求指南(草案)》的发布,预示着美国基于现场检查发现问题的监管模式即将发生转变。本文对质量量度的概念及发展、目标和主要内容进行简介,从质量量度及指南所体现的监管理念方面提出对完善我国药品监管的启示。 The draft of the Request for Quality Metrics Guidance for Industry was issued by the United States Food and Drug Administration( FDA), which indicates that the coming change about the on-site-inspection-based supervision mode in United States. This paper briefly introduced the concept, development,objectives and main contents of quality metrics, and put forward some implications for improving our country' s drug supervision from the regulatory philosophy embodied in quality metrics and the guidance.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2016年第4期260-263,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 美国食品和药物管理局 质量控制 组织状况研究 药品生产质量 United States Food and Drug Administration quality control organizational case studies pharmaceutical produce quality
  • 相关文献

参考文献5

  • 1FDA.Food and Drug Administration drug shortages task force and strategic plan;Request for comments[EB/OL].(2013-02-12)[2015-10-20].https://www.federalregister.gov/articles/2013/02/12/2013-03198/food-and-drug-administration-drug-shortagestask-force-and-strategic-plan-request-for-comments.
  • 2ISPE.ISPE product manufacturing quality metrics initiative[EB/OL].(2015-06-30)[2015-09-30].http://www.pharmaceuticalonline.com/doc/ispe-product-manufacturing-quality-metrics-initiative-0001.
  • 3FDA.Draft guidance for industry:request for quality metrics[EB/OL].(2015-07-27)[2015-09-27].www.fda.gov/downloads/drugs/developmentapprovalprocess/smallbusinessassistance/ucm456211.pdf.
  • 4杜晶晶,胡廷熹.21世纪美国GMP改革的新动向[J].药学进展,2005,29(6):280-284. 被引量:10
  • 5FDA.Remarks at the 18th annual meeting of the international generic pharmaceutical alliance[EB/OL].(2015-09-22)[2015-10-22].http://www.fda.gov/newsevents/speeches/ucm463532.htm.

二级参考文献5

  • 1Department of Health and Human Services.U.S. Food and Drug Administration. Pharmaceutical cGMPs for the 21st century: a risk-based approach[J]. J GXP Compliance, 2002,7(1):90-92.
  • 2Department of Health and Human Services.U.S. Food and Drug Administration. Pharmaceutical cGMPs for the 21st century--a risk-based approach: second progress report and implementation plan[J]. J GXP Compliance,2003,8(1):101-111.
  • 3Department of Health and Human Services.U.S. Food and Drug Administration. Pharmaceutical cGMPs for the 21st Century--a risk-based approach (final report)[EB/OL]. http://www. fda. gov/ cder/ gmp/ gmp 2004/GMP finalreport 2004.htm,2004-9-29.
  • 4齐中熙.我国药品生产将推行CGMP认证[EB/OL].http://news.sohu.com/20041118/n223061614.shtml,2004-11-18.
  • 5胡芳.CGMP认证与中国企业渐行渐近[N].中国医药报,2004,80:86.

共引文献9

同被引文献42

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部